In the UK, commonly prescribed GLP-1 agonists include semaglutide (Ozempic for type 2 diabetes, Rybelsus as an oral option for type 2 diabetes, and Wegovy for weight management), liraglutide (Victoza for diabetes and Saxenda for weight management), and dulaglutide (Trulicity for diabetes)
In an ideal world, both GLP-1s and surgery will continue to be important obesity treatments that can even be complementary to each other
There is no reason to have them more regularly if your client requires it, as normally the average time between a client needing another is after 6 weeks but some people even less, after 4 weeks
The SURMOUNT trial findings in detail A post hoc analysis of the SURMOUNT program examined psychiatric safety specifically
Our team monitors your progress, adjusts dosing when needed, and provides supportive guidance to maintain steady, healthy weight loss